Lineage Cell Therapeutics Inc. — Director's Dealing 2015

Jul 7, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOTIME INC (BTX)
CIK: 0000876343
Period of Report: 2015-07-01

Reporting Person: Cartt Stephen LaHue (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-01	Option to Purchase Common Shares	$3.57	A	20000	Acquired	2020-06-30	Common Shares (20000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares, no par value	80125	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Purchase Common Shares	$3.43	2019-11-03	Common Shares (20000)	20000	Direct

Footnotes

F1: Will become exercisable in four equal quarterly installments based upon continued service on the board of directors.

F2: 5,000 options became exercisable on December 31, 2014; March 31, 2015; and June 30, 2015. The remaining 5,000 options will become exercisable on September 30, 2015 based upon continued service on the board of directors.